Cargando…
Novel Thieno [2,3-b]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism
Due to the role of cancer stem cells (CSCs) in tumor resistance and glycosphingolipid (GSL) involvement in tumor pathogenesis, we investigated the effect of a newly synthesized compound (3-amino-N-(3-chloro-2-methylphenyl)-5-oxo-5,6,7,8-tetrahydrothieno[2,3-b]quinoline-2-carboxamide 1 on the percent...
Autores principales: | Pervan, Matij, Marijan, Sandra, Markotić, Anita, Pilkington, Lisa I., Haverkate, Natalie A., Barker, David, Reynisson, Jóhannes, Meić, Luka, Radan, Mila, Čikeš Čulić, Vedrana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569594/ https://www.ncbi.nlm.nih.gov/pubmed/36232754 http://dx.doi.org/10.3390/ijms231911457 |
Ejemplares similares
-
Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment
por: Marijan, Sandra, et al.
Publicado: (2020) -
Author Correction: Glycosphingolipid expression at breast cancer stem cells after novel thieno[2,3-b]pyridine anticancer compound treatment
por: Marijan, Sandra, et al.
Publicado: (2021) -
Thieno[2,3-b]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s(+) Breast Cancer Cells
por: Marijan, Sandra, et al.
Publicado: (2021) -
Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound
por: Mastelić, Angela, et al.
Publicado: (2017) -
Eta polycaprolactone (ε-PCL) implants appear to cause a partial differentiation of breast cancer lung metastasis in a murine model
por: Benzon, Benjamin, et al.
Publicado: (2023)